{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:20:01Z","timestamp":1787894401273,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,19]]},"DOI":"10.7759\/cureus.49079","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:34:18Z","timestamp":1700462058000},"source":"Crossref","is-referenced-by-count":12,"title":["Novel Advances in the Role of Selective Estrogen Receptor Modulators in Hormonal Replacement Therapy: A Paradigm Shift"],"prefix":"10.7759","author":[{"given":"Gunjan","family":"Motlani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhi","family":"Motlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neema","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Pamnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drishti","family":"Somyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000023528","article-title":"Selective oestrogen receptor modulators","volume":"53 Suppl 3","author":"Burger HG","year":"2000","unstructured":"Burger HG. Selective oestrogen receptor modulators. Horm Res. 2000, 53 Suppl 3:25-9. 10.1159\/000023528","journal-title":"Horm Res"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1023\/A:1020076426727","article-title":"Selective estrogen receptor modulators","volume":"3","author":"Bryant HU","year":"2002","unstructured":"Bryant HU. Selective estrogen receptor modulators. Rev Endocr Metab Disord. 2002, 3:231-41.","journal-title":"Rev Endocr Metab Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000048088","article-title":"Biological effects of hormone replacement therapy in relation to serum estradiol levels","volume":"56","author":"Yasui T","year":"2001","unstructured":"Yasui T, Uemura H, Tezuka M, Yamada M, Irahara M, Miura M, Aono T. Biological effects of hormone replacement therapy in relation to serum estradiol levels. Horm Res. 2001, 56:38-44. 10.1159\/000048088","journal-title":"Horm Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0149-2918(95)80060-3","article-title":"Continuous combined estrogen\/progestin hormone replacement therapy","volume":"17","author":"Andrews WC","year":"1995","unstructured":"Andrews WC. Continuous combined estrogen\/progestin hormone replacement therapy. Clin Ther. 1995, 17:812-26. 10.1016\/0149-2918(95)80060-3","journal-title":"Clin Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101578","article-title":"Menopausal hormone therapy in women with medical conditions","volume":"35","author":"Kapoor E","year":"2021","unstructured":"Kapoor E, Kling JM, Lobo AS, Faubion SS. Menopausal hormone therapy in women with medical conditions. Best Pract Res Clin Endocrinol Metab. 2021, 35:101578. 10.1016\/j.beem.2021.101578","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac158","article-title":"Advances in the development of prodrugs as selective modulators of estrogen receptors","volume":"6","author":"Pollock JA","year":"2022","unstructured":"Pollock JA, Parker HK. Advances in the development of prodrugs as selective modulators of estrogen receptors. J Endocr Soc. 2022, 6:bvac158. 10.1210\/jendso\/bvac158","journal-title":"J Endocr Soc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/bcr78","article-title":"Estrogen receptor transcription and transactivation: estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer","volume":"2","author":"Katzenellenbogen BS","year":"2000","unstructured":"Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor transcription and transactivation: estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res. 2000, 2:335-44. 10.1186\/bcr78","journal-title":"Breast Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1021\/tx060126v","article-title":"Bioactivation of selective estrogen receptor modulators (SERMs)","volume":"19","author":"Dowers TS","year":"2006","unstructured":"Dowers TS, Qin ZH, Thatcher GR, Bolton JL. Bioactivation of selective estrogen receptor modulators (SERMs). Chem Res Toxicol. 2006, 19:1125-37. 10.1021\/tx060126v","journal-title":"Chem Res Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S66690","article-title":"Selective estrogen receptor modulators: tissue specificity and clinical utility","volume":"9","author":"Martinkovich S","year":"2014","unstructured":"Martinkovich S, Shah D, Planey SL, Arnott JA. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging. 2014, 9:1437-52. 10.2147\/CIA.S66690","journal-title":"Clin Interv Aging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.14105","article-title":"Molecular determinants of tissue selectivity in estrogen receptor modulators","volume":"94","author":"Grese TA","year":"1997","unstructured":"Grese TA, Sluka JP, Bryant HU, et al.. Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc Natl Acad Sci U S A. 1997, 94:14105-10. 10.1073\/pnas.94.25.14105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4184\/asj.2016.10.4.787","article-title":"Selective estrogen receptor modulators","volume":"10","author":"An KC","year":"2016","unstructured":"An KC. Selective estrogen receptor modulators. Asian Spine J. 2016, 10:787-91. 10.4184\/asj.2016.10.4.787","journal-title":"Asian Spine J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2021.01418","article-title":"Update on hormone therapy for the management of postmenopausal women","volume":"16","author":"Pan M","year":"2022","unstructured":"Pan M, Pan X, Zhou J, Wang J, Qi Q, Wang L. Update on hormone therapy for the management of postmenopausal women. Biosci Trends. 2022, 16:46-57. 10.5582\/bst.2021.01418","journal-title":"Biosci Trends"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001395.pub4","article-title":"Phytoestrogens for menopausal vasomotor symptoms","volume":"2013","author":"Lethaby A","year":"2013","unstructured":"Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013, 2013:CD001395. 10.1002\/14651858.CD001395.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6118\/jmm.20034","article-title":"Updates on therapeutic alternatives for genitourinary syndrome of menopause: hormonal and non-hormonal managements","volume":"27","author":"Shim S","year":"2021","unstructured":"Shim S, Park KM, Chung YJ, Kim MR. Updates on therapeutic alternatives for genitourinary syndrome of menopause: hormonal and non-hormonal managements. J Menopausal Med. 2021, 27:1-7. 10.6118\/jmm.20034","journal-title":"J Menopausal Med"},{"key":"ref15","article-title":"Hormone replacement therapy: current concerns and considerations","volume":"8","author":"Carroll DG","year":"2002","unstructured":"Carroll DG, Noble SL. Hormone replacement therapy: current concerns and considerations. Am J Manag Care. 2002, 8:663-75.","journal-title":"Am J Manag Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S158913","article-title":"Current treatment options for postmenopausal vaginal atrophy","volume":"10","author":"Naumova I","year":"2018","unstructured":"Naumova I, Castelo-Branco C. Current treatment options for postmenopausal vaginal atrophy. Int J Womens Health. 2018, 10:387-95. 10.2147\/IJWH.S158913","journal-title":"Int J Womens Health"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55100615","article-title":"Vaginal health in menopausal women","volume":"55","author":"Alvisi S","year":"2019","unstructured":"Alvisi S, Gava G, Orsili I, Giacomelli G, Baldassarre M, Seracchioli R, Meriggiola MC. Vaginal health in menopausal women. Medicina (Kaunas). 2019, 55:615. 10.3390\/medicina55100615","journal-title":"Medicina (Kaunas)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2015.1124259","article-title":"Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?","volume":"19","author":"Edwards D","year":"2016","unstructured":"Edwards D, Panay N. Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?. Climacteric. 2016, 19:151-61. 10.3109\/13697137.2015.1124259","journal-title":"Climacteric"},{"key":"ref19","article-title":"Selective estrogen modulators in menopause","volume":"65","author":"Gambacciani M","year":"2013","unstructured":"Gambacciani M. Selective estrogen modulators in menopause. Minerva Ginecol. 2013, 65:621-30.","journal-title":"Minerva Ginecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.564781","article-title":"Risks, benefits, and treatment modalities of menopausal hormone therapy: current concepts","volume":"12","author":"Mehta J","year":"2021","unstructured":"Mehta J, Kling JM, Manson JE. Risks, benefits, and treatment modalities of menopausal hormone therapy: current concepts. Front Endocrinol (Lausanne). 2021, 12:564781. 10.3389\/fendo.2021.564781","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e3283431921","article-title":"Estrogen, hormonal replacement therapy and cardiovascular disease","volume":"20","author":"Yang XP","year":"2011","unstructured":"Yang XP, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011, 20:133-8. 10.1097\/MNH.0b013e3283431921","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.960383","article-title":"Efficacy and safety of a phyto-SERM as an alternative to hormone therapy","volume":"18","author":"S\u00e1nchez-Borrego R","year":"2015","unstructured":"S\u00e1nchez-Borrego R, Navarro MC, Llaneza P, Hormigo A, Duran M, Mendoza N. Efficacy and safety of a phyto-SERM as an alternative to hormone therapy. Climacteric. 2015, 18:350-7. 10.3109\/13697137.2014.960383","journal-title":"Climacteric"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2174\/1574884711308020006","article-title":"The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice","volume":"8","author":"Maximov PY","year":"2013","unstructured":"Maximov PY, Lee TM, Jordan VC. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol. 2013, 8:135-55. 10.2174\/1574884711308020006","journal-title":"Curr Clin Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02158-5","article-title":"Tamoxifen evolution","volume":"128","author":"Howell A","year":"2023","unstructured":"Howell A, Howell SJ. Tamoxifen evolution. Br J Cancer. 2023, 128:421-5. 10.1038\/s41416-023-02158-5","journal-title":"Br J Cancer"},{"key":"ref25","article-title":"Raloxifene: a selective estrogen receptor modulator","volume":"60","author":"Scott JA","year":"1999","unstructured":"Scott JA, Da Camara CC, Early JE. Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999, 60:1131-9.","journal-title":"Am Fam Physician"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003122.pub2","article-title":"Hormone replacement therapy for cognitive function in postmenopausal women","volume":"2008","author":"Lethaby A","year":"2008","unstructured":"Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev. 2008, 2008:CD003122. 10.1002\/14651858.CD003122.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200724050-00002","article-title":"Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development","volume":"24","author":"Gennari L","year":"2007","unstructured":"Gennari L, Merlotti D, Valleggi F, Martini G, Nuti R. Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development. Drugs Aging. 2007, 24:361-79. 10.2165\/00002512-200724050-00002","journal-title":"Drugs Aging"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2217\/17455057.4.4.319","article-title":"Bazedoxifene: a selective estrogen-receptor modulator","volume":"4","author":"Mitwally MF","year":"2008","unstructured":"Mitwally MF. Bazedoxifene: a selective estrogen-receptor modulator. Womens Health (Lond). 2008, 4:319-26. 10.2217\/17455057.4.4.319","journal-title":"Womens Health (Lond)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.191","article-title":"Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women","volume":"26","author":"Cummings SR","year":"2011","unstructured":"Cummings SR, McClung M, Reginster JY, et al.. Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women. J Bone Miner Res. 2011, 26:397-404. 10.1002\/jbmr.191","journal-title":"J Bone Miner Res"},{"key":"ref30","article-title":"Arzoxifene: the evidence for its development in the management of breast cancer","volume":"2","author":"Jackson LR","year":"2008","unstructured":"Jackson LR, Cheung KL, Buzdar AU, Robertson JF. Arzoxifene: the evidence for its development in the management of breast cancer. Core Evid. 2008, 2:251-8.","journal-title":"Core Evid"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S39146","article-title":"Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast","volume":"5","author":"Soe LH","year":"2013","unstructured":"Soe LH, Wurz GT, Kao CJ, Degregorio MW. Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast. Int J Womens Health. 2013, 5:605-11. 10.2147\/IJWH.S39146","journal-title":"Int J Womens Health"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2014.07.012","article-title":"Ospemifene: a first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy","volume":"90","author":"DeGregorio MW","year":"2014","unstructured":"DeGregorio MW, Zerbe RL, Wurz GT. Ospemifene: a first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy. Steroids. 2014, 90:82-93. 10.1016\/j.steroids.2014.07.012","journal-title":"Steroids"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/200386-novel-advances-in-the-role-of-selective-estrogen-receptor-modulators-in-hormonal-replacement-therapy-a-paradigm-shift","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:44Z","timestamp":1707508364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/200386-novel-advances-in-the-role-of-selective-estrogen-receptor-modulators-in-hormonal-replacement-therapy-a-paradigm-shift"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,19]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.49079","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,19]]}}}